Hearscape
Explore

Program Map

Start with a treatment, device, company, diagnosis, or trial ID. Each record keeps the source trail close to the claim.

161Main(26 active)
148Status checked
135Strong
320Backlog
More filters and sort (1 active)
110 records in Main database · 96 strong · 106 status checkedPage 1 of 3
Otarmeni by Regeneron
Regeneron Pharmaceuticals · Gene Therapy · Approved
ApprovedTherapeuticStronger sources
Evidence
regulatory
Confidence
99%
Indications
Hearing LossSensorineural Hearing LossGenetic Hearing LossOTOF-Related Hearing Loss
Population
PediatricAdultCongenitalGenetic
Details
Apple AirPods Pro Hearing Health Features
Apple · Hearing Aid/Software · Marketed
MarketedSoftware/NeurotechOTC Hearing AidsStronger sources
Evidence
regulatory
Confidence
97%
Indications
Hearing LossSensorineural Hearing LossAge-Related Hearing Loss
Population
AdultAge-RelatedPost-Lingual
Details
AK-OTOF by Eli Lilly and Akouos
Eli Lilly and Company · Gene Therapy · Phase 2
ActiveTherapeuticStronger sources
Evidence
trial
Confidence
95%
Indications
Hearing LossSensorineural Hearing LossGenetic Hearing LossOTOF-Related Hearing Loss
Population
PediatricAdultCongenitalGenetic
Details
Nuance Audio Hearing Aid Software
EssilorLuxottica · Hearing Aid/Software · Marketed
MarketedSoftware/NeurotechOTC Hearing AidsStronger sources
Evidence
regulatory
Confidence
95%
Indications
Hearing LossSensorineural Hearing LossAge-Related Hearing Loss
Population
AdultAge-RelatedPost-Lingual
Details
Cochlear Nucleus Nexa System
Cochlear · Cochlear/Auditory Implant · Marketed
MarketedDeviceCochlear ImplantsStronger sources
Evidence
company
Confidence
94%
Indications
Hearing LossSensorineural Hearing Loss
Population
PediatricAdultBilateralProfound
Details
SENS-401 (Arazasetron) by Sensorion
Sensorion · Small Molecule · Phase 2
ActiveTherapeuticStronger sources
Evidence
company
Confidence
94%
Indications
Hearing LossSensorineural Hearing LossSudden Sensorineural Hearing LossCisplatin-Induced Hearing Loss
Population
AdultSudden / SSNHLCisplatin OtotoxicityCochlear Implant
Details
SENS-501 by Sensorion
Sensorion · Gene Therapy · Phase 1/2
ActiveTherapeuticStronger sources
Evidence
trial
Confidence
94%
Indications
Hearing LossSensorineural Hearing LossGenetic Hearing LossOTOF-Related Hearing Loss
Population
PediatricCongenitalGeneticOTOF / DFNB9
Details
Envoy Medical Acclaim Cochlear Implant
Envoy Medical · Cochlear/Auditory Implant · Phase 2/3
ActiveDeviceCochlear ImplantsStronger sources
Evidence
trial
Confidence
93%
Indications
Hearing LossSensorineural Hearing Loss
Population
AdultPost-LingualProfound
Details
MED-EL SYNCHRONY Cochlear Implant System
MED-EL · Cochlear/Auditory Implant · Marketed
MarketedDeviceCochlear ImplantsStronger sources
Evidence
regulatory
Confidence
93%
Indications
Hearing LossSensorineural Hearing Loss
Population
PediatricAdultBilateralProfound
Details
Cochlear Nucleus Profile Plus CI600 Series Implants
Cochlear · Cochlear/Auditory Implant · Marketed
MarketedDeviceCochlear ImplantsStronger sources
Evidence
company
Confidence
92%
Indications
Hearing LossSensorineural Hearing LossCochlear Implant
Population
PediatricAdultCochlear ImplantImplantable Device
Details
Phonak Audéo Sphere Infinio
Phonak · Hearing Aid/Software · Marketed
MarketedDeviceAI AudioStronger sources
Evidence
company
Confidence
92%
Indications
Hearing LossSensorineural Hearing LossAge-Related Hearing Loss
Population
AdultAge-RelatedPost-LingualModerate to Severe
Details
Rincell-1 by Rinri Therapeutics
Rinri Therapeutics · Cell Therapy · Phase 1/2
ActiveTherapeuticStronger sources
Evidence
trial
Confidence
92%
Indications
Hearing LossSensorineural Hearing LossAge-Related Hearing LossAuditory Neuropathy
Population
AdultAge-RelatedAuditory Neuropathy
Details
AC102 by AudioCure Pharma
AudioCure Pharma · Small Molecule · Phase 2
ActiveTherapeuticStronger sources
Evidence
trial
Confidence
91%
Indications
Hearing LossSensorineural Hearing LossSudden Sensorineural Hearing LossTinnitus
Population
AdultSudden / SSNHLTinnitus
Details
HIMSA Noah ES and Noah System
HIMSA · Fitting Software/Workflow · Marketed
MarketedSoftware/NeurotechFitting SoftwareStronger sources
Evidence
company
Confidence
91%
Indications
Hearing LossSensorineural Hearing Loss
Population
AdultPediatricClinical AudiologyFitting Workflow
Details
ReSound Vivia
GN ReSound · Hearing Aid/Software · Marketed
MarketedDeviceAI AudioStronger sources
Evidence
company
Confidence
90%
Indications
Hearing LossSensorineural Hearing LossAge-Related Hearing Loss
Population
AdultAge-RelatedPost-LingualModerate to Severe
Details
SPI-1005 by Sound Pharmaceuticals
Sound Pharmaceuticals · Small Molecule · Phase 3
ActiveTherapeuticStronger sources
Evidence
trial
Confidence
90%
Indications
Hearing LossSensorineural Hearing LossNoise-Induced Hearing LossTinnitus
Population
AdultNoise-InducedTinnitusCisplatin Ototoxicity
Details
Envoy Medical Esteem Fully Implanted Hearing System
Envoy Medical · Active Middle Ear Implant · Marketed
MarketedDeviceBone Conduction & Middle EarStronger sources
Evidence
regulatory
Confidence
97%
Indications
Hearing LossSensorineural Hearing Loss
Population
AdultModerate to SeverePost-LingualActive Middle Ear Implant
Details
Cochlear Osia System
Cochlear · Cochlear/Auditory Implant · Marketed
MarketedDeviceBone Conduction & Middle EarStronger sources
Evidence
regulatory
Confidence
96%
Indications
Hearing LossConductive Hearing LossMixed Hearing LossSensorineural Hearing Loss
Population
PediatricAdultUnilateralBilateral
Details
MED-EL VIBRANT SOUNDBRIDGE
MED-EL · Cochlear/Auditory Implant · Marketed
MarketedDeviceBone Conduction & Middle EarStronger sources
Evidence
regulatory
Confidence
95%
Indications
Hearing LossSensorineural Hearing LossConductive Hearing LossMixed Hearing Loss
Population
AdultUnilateralBilateralModerate to Severe
Details
ACOU085 by Acousia Therapeutics
Acousia Therapeutics GmbH · Small Molecule · Phase 2
ActiveTherapeuticStronger sources
Evidence
company
Confidence
93%
Indications
Hearing LossSensorineural Hearing LossAge-Related Hearing LossCisplatin-Induced Hearing Loss
Population
AdultAge-RelatedCisplatin Ototoxicity
Details
CIL001 (Paliroden) by Cilcare
Cilcare SAS · Small Molecule · Phase 1/2
ActiveTherapeuticStronger sources
Evidence
trial
Confidence
92%
Indications
Hearing LossSensorineural Hearing LossHidden Hearing LossCochlear Synaptopathy
Population
AdultDiabetesCochlear SynaptopathyHidden Hearing Loss
Details
Cochlear Baha System
Cochlear · Cochlear/Auditory Implant · Marketed
MarketedDeviceBone Conduction & Middle EarStronger sources
Evidence
company
Confidence
92%
Indications
Hearing LossConductive Hearing LossMixed Hearing LossSensorineural Hearing Loss
Population
PediatricAdultUnilateralBilateral
Details
NS101 by Neuracle Science
Neuracle Science Co., Ltd. · Biologic · Phase 1/2
ActiveTherapeuticStronger sources
Evidence
trial
Confidence
92%
Indications
Hearing LossSensorineural Hearing LossSudden Sensorineural Hearing LossCochlear Synaptopathy
Population
AdultSudden / SSNHLSensorineuralSalvage Therapy
Details
Earlens Contact Hearing Solution
Earlens Corporation · Bone Conduction / Middle-Ear Device · Marketed
MarketedDeviceBone Conduction & Middle EarStronger sources
Evidence
regulatory
Confidence
91%
Indications
Hearing LossSensorineural Hearing LossConductive Hearing LossMixed Hearing Loss
Population
AdultClinical AudiologyMiddle Ear AssessmentTympanic Contact Device
Details
GeoAxon Kuduwave Pro
GeoAxon · Diagnostic · Marketed
MarketedDiagnosticDiagnosticsStronger sources
Evidence
company
Confidence
91%
Indications
Hearing LossSensorineural Hearing Loss
Population
AdultPediatricClinical AudiologyPortable Diagnostics
Details
Phonak Audéo Infinio Ultra R
Phonak · Prescription Hearing Aid · Marketed
MarketedDevicePrescription Hearing AidsStronger sources
Evidence
company
Confidence
91%
Indications
Hearing LossSensorineural Hearing LossSingle-Sided Deafness
Population
AdultPrescription Hearing AidReceiver In CanalRechargeable
Details
ReSound Nexia
GN ReSound · Prescription Hearing Aid · Marketed
MarketedDevicePrescription Hearing AidsStronger sources
Evidence
company
Confidence
91%
Indications
Hearing LossSensorineural Hearing LossSingle-Sided Deafness
Population
AdultPrescription Hearing AidReceiver In CanalBehind The Ear
Details
Signia Integrated Xperience
Signia · Hearing Aid/Software · Marketed
MarketedDeviceAI AudioStronger sources
Evidence
company
Confidence
91%
Indications
Hearing LossSensorineural Hearing LossAge-Related Hearing Loss
Population
AdultAge-RelatedPost-LingualModerate to Severe
Details
Signia Silk Charge&Go IX
Signia · Prescription Hearing Aid · Marketed
MarketedDevicePrescription Hearing AidsStronger sources
Evidence
company
Confidence
91%
Indications
Hearing LossSensorineural Hearing Loss
Population
AdultPrescription Hearing AidCompletely In CanalInstant Fit
Details
Audioscan Verifit2
Audioscan · Diagnostic/Fitting Verification · Marketed
MarketedDiagnosticDiagnosticsStronger sources
Evidence
company
Confidence
90%
Indications
Hearing LossSensorineural Hearing Loss
Population
AdultPediatricClinical AudiologyFitting Verification
Details
Cochlear Custom Sound Pro Fitting Software
Cochlear · Cochlear Implant Programming Software/Workflow · Marketed
MarketedSoftware/NeurotechFitting SoftwareStronger sources
Evidence
company
Confidence
90%
Indications
Hearing LossSensorineural Hearing LossCochlear Implant
Population
PediatricAdultPost Implant Programming
Details
Cochlear Nucleus 8 Sound Processor
Cochlear · Cochlear/Auditory Implant · Marketed
MarketedDeviceCochlear ImplantsStronger sources
Evidence
company
Confidence
90%
Indications
Hearing LossSensorineural Hearing LossCochlear Implant
Population
PediatricAdultPost Implant ProgrammingProfound
Details
Cochlear Nucleus Kanso 3 Sound Processor
Cochlear · Cochlear/Auditory Implant · Marketed
MarketedDeviceCochlear ImplantsStronger sources
Evidence
company
Confidence
90%
Indications
Hearing LossSensorineural Hearing LossCochlear Implant
Population
PediatricAdultCochlear ImplantPost Implant Programming
Details
Interacoustics Affinity Compact
Interacoustics · Diagnostic/Fitting Verification · Marketed
MarketedDiagnosticDiagnosticsStronger sources
Evidence
company
Confidence
90%
Indications
Hearing LossSensorineural Hearing Loss
Population
AdultPediatricClinical AudiologyFitting Verification
Details
Natus AURICAL FreeFit
Natus · Diagnostic/Fitting Verification · Marketed
MarketedDiagnosticDiagnosticsStronger sources
Evidence
company
Confidence
90%
Indications
Hearing LossSensorineural Hearing Loss
Population
AdultPediatricClinical AudiologyFitting Verification
Details
Phonak Lyric
Phonak · Hearing Aid/Software · Marketed
MarketedDevicePrescription Hearing AidsStronger sources
Evidence
company
Confidence
90%
Indications
Hearing LossSensorineural Hearing LossAge-Related Hearing Loss
Population
AdultAge-RelatedPost-LingualModerate to Severe
Details
Phonak Naída Lumity Power Hearing Aids
Phonak · Prescription Hearing Aid · Marketed
MarketedDevicePrescription Hearing AidsStronger sources
Evidence
company
Confidence
90%
Indications
Hearing LossSensorineural Hearing LossMixed Hearing Loss
Population
AdultPrescription Hearing AidBehind The EarPower Hearing Aid
Details
Phonak Sky Lumity Pediatric Hearing Aids
Phonak · Prescription Hearing Aid · Marketed
MarketedDevicePrescription Hearing AidsStronger sources
Evidence
company
Confidence
90%
Indications
Hearing LossSensorineural Hearing LossCongenital Hearing Loss
Population
PediatricCongenitalPrescription Hearing AidBehind The Ear
Details
Starkey Edge AI
Starkey · Hearing Aid/Software · Marketed
MarketedDeviceAI AudioStronger sources
Evidence
company
Confidence
90%
Indications
Hearing LossSensorineural Hearing LossAge-Related Hearing Loss
Population
AdultAge-RelatedPost-LingualModerate to Severe
Details
Widex Allure
Widex · Hearing Aid/Software · Marketed
MarketedDeviceAI AudioStronger sources
Evidence
company
Confidence
90%
Indications
Hearing LossSensorineural Hearing LossAge-Related Hearing Loss
Population
AdultAge-RelatedPost-LingualModerate to Severe
Details
Advanced Bionics Sky CI M Sound Processor
Advanced Bionics · Cochlear/Auditory Implant · Marketed
MarketedDeviceCochlear ImplantsStronger sources
Evidence
company
Confidence
89%
Indications
Hearing LossSensorineural Hearing LossCochlear Implant
Population
PediatricCochlear ImplantProfoundBimodal
Details
HIMSA Noahlink Wireless 2
HIMSA · Hearing Aid Programming Interface · Marketed
MarketedDeviceFitting SoftwareStronger sources
Evidence
company
Confidence
89%
Indications
Hearing LossSensorineural Hearing Loss
Population
AdultPediatricClinical AudiologyFitting Workflow
Details
MED-EL MAESTRO 11 Fitting Software
MED-EL · Cochlear Implant Programming Software/Workflow · Marketed
MarketedSoftware/NeurotechFitting SoftwareStronger sources
Evidence
company
Confidence
89%
Indications
Hearing LossSensorineural Hearing LossCochlear Implant
Population
PediatricAdultPost Implant Programming
Details
Oticon Intent
Oticon · Hearing Aid/Software · Marketed
MarketedDeviceAI AudioStronger sources
Evidence
company
Confidence
89%
Indications
Hearing LossSensorineural Hearing LossAge-Related Hearing Loss
Population
AdultAge-RelatedPost-LingualModerate to Severe
Details
Advanced Bionics Target CI Fitting Software
Advanced Bionics · Cochlear Implant Programming Software/Workflow · Marketed
MarketedSoftware/NeurotechFitting SoftwareStronger sources
Evidence
company
Confidence
88%
Indications
Hearing LossSensorineural Hearing LossCochlear Implant
Population
PediatricAdultPost Implant Programming
Details
GJB2-GT by Sensorion
Sensorion · Gene Therapy · Preclinical
ActiveTherapeuticStronger sources
Evidence
company
Confidence
88%
Indications
Hearing LossSensorineural Hearing LossGenetic Hearing Loss
Population
CongenitalGeneticPre-Lingual
Details
Jabra Enhance Select 700
Jabra Enhance · Hearing Aid/Software · Marketed
MarketedDeviceOTC Hearing AidsStronger sources
Evidence
company
Confidence
88%
Indications
Hearing LossSensorineural Hearing LossAge-Related Hearing Loss
Population
AdultAge-RelatedMild to ModeratePost-Lingual
Details
MED-EL FLEX Series Cochlear Implant Electrode Arrays
MED-EL · Cochlear/Auditory Implant · Marketed
MarketedDeviceCochlear ImplantsStronger sources
Evidence
company
Confidence
88%
Indications
Hearing LossSensorineural Hearing LossCochlear Implant
Population
PediatricAdultCochlear ImplantImplantable Device
Details
MED-EL RONDO 3 Audio Processor
MED-EL · Cochlear/Auditory Implant · Marketed
MarketedDeviceCochlear ImplantsStronger sources
Evidence
company
Confidence
88%
Indications
Hearing LossSensorineural Hearing LossCochlear Implant
Population
PediatricAdultPost Implant ProgrammingProfound
Details